| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/14/1998 | US5780266 Feline infectious peritonitis virus diagnostic tools |
| 07/14/1998 | US5780265 Kunitz type plasma kallikrein inhibitors |
| 07/14/1998 | US5780264 Iron transport protein |
| 07/14/1998 | US5780263 Human CCN-like growth factor |
| 07/14/1998 | US5780262 Max-interacting proteins and related molecules and methods |
| 07/14/1998 | US5780245 Polypeptides having a serotonin receptor activity, nucleic acids coding for these polypeptides and uses |
| 07/14/1998 | US5780238 VPR receptor protein |
| 07/14/1998 | US5780235 Genetically engineered expression vectors; forming hybridization complex; detection |
| 07/14/1998 | US5780230 Compositions and methods for human sperm activation and quantitative assessment of human sperm genome replication |
| 07/14/1998 | US5780229 Analyzing alloantigen phenotypes |
| 07/14/1998 | US5780228 High affinity nucleic acid ligands to lectins |
| 07/14/1998 | US5780223 Gene disorder; measuring in the sample the presence or absence of a dna deletion or duplication using probe that hydridizes to low copy repeat sequences within charcot-marie-tooth syndrome disease type 1 region |
| 07/14/1998 | US5780221 Identification of enantiomeric ligands |
| 07/14/1998 | US5780220 Methods and compositions for inhibiting HIV replication |
| 07/14/1998 | US5780041 Detecting mammals infected with lyme disease |
| 07/14/1998 | US5780040 Helicobacter pylori nickel binding protein |
| 07/14/1998 | US5780038 HIV-2 envelope polypeptides |
| 07/14/1998 | US5780036 Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus |
| 07/14/1998 | US5780032 Method of using monoclonal antibodies to cytokeratin fragments |
| 07/14/1998 | US5780030 Passive vaccine against Lyme disease |
| 07/14/1998 | US5780027 Methods of treatment of down syndrome by interferon antagonists |
| 07/14/1998 | US5780024 Superoxide dismutase/tetanus toxin fragment C hybrid protein |
| 07/14/1998 | US5780021 Preventing or treating an autoimmune disorder and/or recurrent autoimmune disorder in a transplanted pancreatic or islet tissue in a mammal, which entails administering natural type 1 interferon, a synthetic type 1 interferon or hybrid |
| 07/14/1998 | US5780009 Milk production |
| 07/14/1998 | US5780007 Technetium-99m labeled peptides for imaging |
| 07/14/1998 | CA2127330C Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 07/14/1998 | CA1339955C Process for transforming a human insulin precursor to human insulin |
| 07/14/1998 | CA1339954C Dogs - and horse - interferones |
| 07/14/1998 | CA1339952C Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto |
| 07/10/1998 | CA2226695A1 H2-m modified transgenic animals |
| 07/10/1998 | CA2219960A1 Cdna clone he8cs41 that encodes a novel 7-transmembrane receptor |
| 07/09/1998 | WO1998029747A1 Reagents and methods for detecting hepatitis gb virus antigen |
| 07/09/1998 | WO1998029566A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029565A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029559A1 Process for preparing purified dimer of bone-derived factor |
| 07/09/1998 | WO1998029556A1 Recombinant adenoviral vector expressing antigens associated with colorectal tumors |
| 07/09/1998 | WO1998029555A2 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 07/09/1998 | WO1998029551A1 THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1) |
| 07/09/1998 | WO1998029550A1 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis |
| 07/09/1998 | WO1998029549A1 The process for the expression and production of the recombinant growth factor protein (begf) derived from bean 58058 virus (bev) |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029547A1 Modulators of radial glia-astrocyte differentiation and transformation, and diagnostic and therapeutic uses thereof |
| 07/09/1998 | WO1998029546A1 Human rhombotin-like protein |
| 07/09/1998 | WO1998029545A1 NOVEL SEQUENCES OF p56 PROTEINS WHICH AFFECT K-ATP CHANNELS |
| 07/09/1998 | WO1998029544A1 Novel peptide, novel dna, and novel antibody |
| 07/09/1998 | WO1998029543A1 Compounds for modulating cell negative regulations and biological applications thereof |
| 07/09/1998 | WO1998029540A2 RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF EUROPEAN MISTLETOE $i(VISCUM ALBUM) |
| 07/09/1998 | WO1998029539A2 Partial sequences of purine biosynthesis genes from ashbya gossypii and their use in the microbial riboflavin synthesis |
| 07/09/1998 | WO1998029538A2 Gene for adenylate cyclase and its use |
| 07/09/1998 | WO1998029537A2 Method for protecting plants |
| 07/09/1998 | WO1998029535A2 Nanoscale particles synthesized within an assembled virion |
| 07/09/1998 | WO1998029453A1 Cell membrane-directed drugs |
| 07/09/1998 | WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use |
| 07/09/1998 | WO1998029451A1 Method for elevating the concentration of free insulin-like growth factor |
| 07/09/1998 | WO1998029450A1 Antigenic peptides reacting with anti-ovary antibodies |
| 07/09/1998 | WO1998029448A1 Human pathogenesis-related protein |
| 07/09/1998 | WO1998029447A1 Novel human apoptosis regulator |
| 07/09/1998 | WO1998029446A1 Neuropeptides originating in scorpion |
| 07/09/1998 | WO1998029445A1 α-AMINO-BUTYRATE DERIVATIVES OF VENOMS |
| 07/09/1998 | WO1998029444A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 07/09/1998 | WO1998029443A1 Multiple branch peptide constructions |
| 07/09/1998 | WO1998029442A1 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES |
| 07/09/1998 | WO1998029441A1 Human galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029440A1 Mouse galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029439A1 Galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | WO1998029438A2 Cortistatin polypeptides |
| 07/09/1998 | WO1998029437A2 Mammalian equilibrative nucleoside transporters |
| 07/09/1998 | WO1998029436A2 Lebetin peptides as platelet aggregation inhibitors |
| 07/09/1998 | WO1998029433A2 Method for solubilization and naturation of somatotropins |
| 07/09/1998 | WO1998029432A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 07/09/1998 | WO1998029431A1 Method to diagnose and treat pathological conditions resulting from deficient ion transport |
| 07/09/1998 | WO1998029128A1 Biologically active substances, method for obtaining and compositions containing them |
| 07/09/1998 | WO1998029109A1 Methods and compositions for identification of autoantigens |
| 07/09/1998 | WO1998028971A2 Transgenic animals for in vivo visualization of beta-amyloid toxicity |
| 07/09/1998 | WO1998023639A3 Shk toxin compositions and methods of use |
| 07/09/1998 | WO1998021334A3 Antibody mg1 recognizing a small subset of human hematopoietic cells |
| 07/09/1998 | WO1998021232A3 Mutant forms of fas ligand and uses thereof |
| 07/09/1998 | WO1998018818A3 Hepatitis b inhibitors |
| 07/09/1998 | WO1998017796A3 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 07/09/1998 | WO1998015650A3 Hydronephrosis gene (hng) and its use |
| 07/09/1998 | WO1998015635A3 Treatment of cancer using a recombinant poxvirus containing a nucleic acid sequence encoding a cytokine |
| 07/09/1998 | WO1998008542A3 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 07/09/1998 | WO1998007745A3 Compositions and methods for treating infections using analogues of indolicidin |
| 07/09/1998 | WO1998005780A3 Voltage-gated calcium channel antagonist and methods |
| 07/09/1998 | DE19729248C1 Protein for use as electrophoretic standard |
| 07/09/1998 | CA2282662A1 Human galanin receptor galr2 and nucleotides encoding same |
| 07/09/1998 | CA2278340A1 Novel human apoptosis regulator |
| 07/09/1998 | CA2276745A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
| 07/09/1998 | CA2276573A1 Nanoscale particles synthesized within an assembled virion |
| 07/09/1998 | CA2276490A1 Antigenic peptides reacting with anti-ovary antibodies |
| 07/09/1998 | CA2276252A1 Method for solubilization and naturation of somatotropins |
| 07/09/1998 | CA2276112A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 07/09/1998 | CA2276110A1 Gene for adenylate cyclase and its use |
| 07/09/1998 | CA2276093A1 Partial sequences of purine biosynthesis genes from ashbya gossypii and their use in the microbial riboflavin synthesis |
| 07/09/1998 | CA2276091A1 Cell membrane-directed drugs |
| 07/09/1998 | CA2276086A1 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis |
| 07/09/1998 | CA2276049A1 Method for elevating the concentration of free insulin-like growth factor |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/09/1998 | CA2275854A1 Method for protecting plants |
| 07/09/1998 | CA2275544A1 Lebetin peptides as platelet aggregation inhibitors |